27 Patient demographics captured age; sex; SES (IMD1 (least deprived) to IMD5 (most deprived23)) and comorbidities, including anxiety, atopy, chronic obstructive pulmonary disease (COPD), gastro ...

Adopting target saturations 88%–92% for all hospitalised patients with COPD would simplify clinical pathways and should improve outcomes ... Guidelines from the BTS and endorsed by the ERS state that ...

In 2019, COPD was responsible for ... all designed to act on specific molecular pathways and tailored to selected patient populations. Beyond drug treatments, several non-pharmacological ...

The success of Dupixent has demonstrated the viability of biologics in COPD ... have paved the way for a new treatment paradigm, targeting specific inflammatory pathways to reduce exacerbations ...

While historically regarded as a disease primarily affecting men, COPD now has a more significant presence in women, marking an urgent need for gender-specific diagnosis and treatment strategies.

Verona Pharma is off to a promising start as it launches its first product, Ohtuvayre, a maintenance treatment for chronic obstructive pulmonary disorder (COPD). In 2024, Ohtuvayre generated sales ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched pairs of ...

Perth: Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

A new form of treatment for serious asthma and chronic obstructive pulmonary disease (COPD) could be “a game changer” for patients, according to respiratory experts. Doctors said the new way ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published ...

AstraZeneca’s aim is to reverse the progression of COPD, transform treatment goals and improve patient outcomes,” he added. Breztri Aerosphere® has been available as a maintenance treatment ...

A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options. We live longer and longer ...